Please login to the form below
Relief Therapeutics
This page shows the latest Relief Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout
Relief Therapeutics has announced that its NeuroRX-partnered COVID-19 drug RLF-100 met the survival threshold in intensive care patients and added that it expects detailed trial data this year. ... Relief and NeuroRx are still awaiting the detailed
Latest news
-
Relief Therapeutics seeks US emergency approval for COVID-19 drug
According to Relief Therapeutics, patients treated with RLF-100 demonstrated a three-fold advantage in survival, as well as recovery from respiratory failure and other clinical improvement parameters. ... The pursuit of EUA status is a crucial component
-
NeuroRx, Relief Therapeutics’ COVID-19 drug demonstrates early potential
Drug produced rapid recovery in critically-ill patients. NeuroRx and Relief Therapeutics have announced that their investigational therapeutic RLF-100 produces rapid recovery from respiratory failure in critically-ill COVID-19 ... NeuroRx and Relief have
-
Halozyme to resume pancreatic cancer study
FDA says PEGPH20 trial can continue. There was relief for Halozyme Therapeutics after it was told it can resume a clinical study investigating a potential treatment for pancreatic cancer.
More from news
Approximately 3 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- COVID-19 vaccine developers respond to new strain
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- bluebird bio to separate oncology and rare diseases units
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
